Report Detail
COVID-19 Impact on Global Hereditary Angioedema Treatment Market Insights, Forecast to 2026
- RnM4069950 |
- 19 June, 2020 |
- Global |
- 111 Pages |
- QYResearch |
- Pharma & Healthcare
Hereditary Angioedema Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Hereditary Angioedema Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Hereditary Angioedema Treatment market is segmented into
C1 Estearse Inhibitors (Plasma Products, Recombinant Products)
Selective Bradykinin B2 Receptor Antagonists (Firazyr)
Kallikrein Inhibitors (Kalbitor, Takhzyro)
Others (Conventional Drugs, Pipeline Drugs)
Segment by Application, the Hereditary Angioedema Treatment market is segmented into
Hospital Pharmacies
Retail Pharmacies
Others (online pharmacies, mail pharmacies)
Regional and Country-level Analysis
The Hereditary Angioedema Treatment market is analysed and market size information is provided by regions (countries).
The key regions covered in the Hereditary Angioedema Treatment market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Hereditary Angioedema Treatment Market Share Analysis
Hereditary Angioedema Treatment market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Hereditary Angioedema Treatment business, the date to enter into the Hereditary Angioedema Treatment market, Hereditary Angioedema Treatment product introduction, recent developments, etc.
The major vendors covered:
CSL
Pharming Group
Shire plc (Takeda Pharmaceutical Company Limited)
Ionis Pharmaceuticals
Attune Pharmaceuticals
BioCryst Pharmaceuticals
KalVista Pharmaceuticals
...
1 Study Coverage
- 1.1 Hereditary Angioedema Treatment Product Introduction
- 1.2 Market Segments
- 1.3 Key Hereditary Angioedema Treatment Manufacturers Covered: Ranking by Revenue
- 1.4 Market by Type
- 1.4.1 Global Hereditary Angioedema Treatment Market Size Growth Rate by Type
- 1.4.2 C1 Estearse Inhibitors (Plasma Products, Recombinant Products)
- 1.4.3 Selective Bradykinin B2 Receptor Antagonists (Firazyr)
- 1.4.4 Kallikrein Inhibitors (Kalbitor, Takhzyro)
- 1.4.5 Others (Conventional Drugs, Pipeline Drugs)
- 1.5 Market by Application
- 1.5.1 Global Hereditary Angioedema Treatment Market Size Growth Rate by Application
- 1.5.2 Hospital Pharmacies
- 1.5.3 Retail Pharmacies
- 1.5.4 Others (online pharmacies, mail pharmacies)
- 1.6 Coronavirus Disease 2019 (Covid-19): Hereditary Angioedema Treatment Industry Impact
- 1.6.1 How the Covid-19 is Affecting the Hereditary Angioedema Treatment Industry
- 1.6.1.1 Hereditary Angioedema Treatment Business Impact Assessment - Covid-19
- 1.6.1.2 Supply Chain Challenges
- 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
- 1.6.2 Market Trends and Hereditary Angioedema Treatment Potential Opportunities in the COVID-19 Landscape
- 1.6.3 Measures / Proposal against Covid-19
- 1.6.3.1 Government Measures to Combat Covid-19 Impact
- 1.6.3.2 Proposal for Hereditary Angioedema Treatment Players to Combat Covid-19 Impact
- 1.6.1 How the Covid-19 is Affecting the Hereditary Angioedema Treatment Industry
- 1.7 Study Objectives
- 1.8 Years Considered
2 Executive Summary
- 2.1 Global Hereditary Angioedema Treatment Market Size Estimates and Forecasts
- 2.1.1 Global Hereditary Angioedema Treatment Revenue 2015-2026
- 2.1.2 Global Hereditary Angioedema Treatment Sales 2015-2026
- 2.2 Hereditary Angioedema Treatment Market Size by Region: 2020 Versus 2026
- 2.2.1 Global Hereditary Angioedema Treatment Retrospective Market Scenario in Sales by Region: 2015-2020
- 2.2.2 Global Hereditary Angioedema Treatment Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Hereditary Angioedema Treatment Competitor Landscape by Players
- 3.1 Hereditary Angioedema Treatment Sales by Manufacturers
- 3.1.1 Hereditary Angioedema Treatment Sales by Manufacturers (2015-2020)
- 3.1.2 Hereditary Angioedema Treatment Sales Market Share by Manufacturers (2015-2020)
- 3.2 Hereditary Angioedema Treatment Revenue by Manufacturers
- 3.2.1 Hereditary Angioedema Treatment Revenue by Manufacturers (2015-2020)
- 3.2.2 Hereditary Angioedema Treatment Revenue Share by Manufacturers (2015-2020)
- 3.2.3 Global Hereditary Angioedema Treatment Market Concentration Ratio (CR5 and HHI) (2015-2020)
- 3.2.4 Global Top 10 and Top 5 Companies by Hereditary Angioedema Treatment Revenue in 2019
- 3.2.5 Global Hereditary Angioedema Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
- 3.3 Hereditary Angioedema Treatment Price by Manufacturers
- 3.4 Hereditary Angioedema Treatment Manufacturing Base Distribution, Product Types
- 3.4.1 Hereditary Angioedema Treatment Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Hereditary Angioedema Treatment Product Type
- 3.4.3 Date of International Manufacturers Enter into Hereditary Angioedema Treatment Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
- 4.1 Global Hereditary Angioedema Treatment Market Size by Type (2015-2020)
- 4.1.1 Global Hereditary Angioedema Treatment Sales by Type (2015-2020)
- 4.1.2 Global Hereditary Angioedema Treatment Revenue by Type (2015-2020)
- 4.1.3 Hereditary Angioedema Treatment Average Selling Price (ASP) by Type (2015-2026)
- 4.2 Global Hereditary Angioedema Treatment Market Size Forecast by Type (2021-2026)
- 4.2.1 Global Hereditary Angioedema Treatment Sales Forecast by Type (2021-2026)
- 4.2.2 Global Hereditary Angioedema Treatment Revenue Forecast by Type (2021-2026)
- 4.2.3 Hereditary Angioedema Treatment Average Selling Price (ASP) Forecast by Type (2021-2026)
- 4.3 Global Hereditary Angioedema Treatment Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Breakdown Data by Application (2015-2026)
- 5.1 Global Hereditary Angioedema Treatment Market Size by Application (2015-2020)
- 5.1.1 Global Hereditary Angioedema Treatment Sales by Application (2015-2020)
- 5.1.2 Global Hereditary Angioedema Treatment Revenue by Application (2015-2020)
- 5.1.3 Hereditary Angioedema Treatment Price by Application (2015-2020)
- 5.2 Hereditary Angioedema Treatment Market Size Forecast by Application (2021-2026)
- 5.2.1 Global Hereditary Angioedema Treatment Sales Forecast by Application (2021-2026)
- 5.2.2 Global Hereditary Angioedema Treatment Revenue Forecast by Application (2021-2026)
- 5.2.3 Global Hereditary Angioedema Treatment Price Forecast by Application (2021-2026)
6 North America
- 6.1 North America Hereditary Angioedema Treatment by Country
- 6.1.1 North America Hereditary Angioedema Treatment Sales by Country
- 6.1.2 North America Hereditary Angioedema Treatment Revenue by Country
- 6.1.3 U.S.
- 6.1.4 Canada
- 6.2 North America Hereditary Angioedema Treatment Market Facts & Figures by Type
- 6.3 North America Hereditary Angioedema Treatment Market Facts & Figures by Application
7 Europe
- 7.1 Europe Hereditary Angioedema Treatment by Country
- 7.1.1 Europe Hereditary Angioedema Treatment Sales by Country
- 7.1.2 Europe Hereditary Angioedema Treatment Revenue by Country
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 U.K.
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Hereditary Angioedema Treatment Market Facts & Figures by Type
- 7.3 Europe Hereditary Angioedema Treatment Market Facts & Figures by Application
8 Asia Pacific
- 8.1 Asia Pacific Hereditary Angioedema Treatment by Region
- 8.1.1 Asia Pacific Hereditary Angioedema Treatment Sales by Region
- 8.1.2 Asia Pacific Hereditary Angioedema Treatment Revenue by Region
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 South Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Taiwan
- 8.1.9 Indonesia
- 8.1.10 Thailand
- 8.1.11 Malaysia
- 8.1.12 Philippines
- 8.1.13 Vietnam
- 8.2 Asia Pacific Hereditary Angioedema Treatment Market Facts & Figures by Type
- 8.3 Asia Pacific Hereditary Angioedema Treatment Market Facts & Figures by Application
9 Latin America
- 9.1 Latin America Hereditary Angioedema Treatment by Country
- 9.1.1 Latin America Hereditary Angioedema Treatment Sales by Country
- 9.1.2 Latin America Hereditary Angioedema Treatment Revenue by Country
- 9.1.3 Mexico
- 9.1.4 Brazil
- 9.1.5 Argentina
- 9.2 Central & South America Hereditary Angioedema Treatment Market Facts & Figures by Type
- 9.3 Central & South America Hereditary Angioedema Treatment Market Facts & Figures by Application
10 Middle East and Africa
- 10.1 Middle East and Africa Hereditary Angioedema Treatment by Country
- 10.1.1 Middle East and Africa Hereditary Angioedema Treatment Sales by Country
- 10.1.2 Middle East and Africa Hereditary Angioedema Treatment Revenue by Country
- 10.1.3 Turkey
- 10.1.4 Saudi Arabia
- 10.1.5 U.A.E
- 10.2 Middle East and Africa Hereditary Angioedema Treatment Market Facts & Figures by Type
- 10.3 Middle East and Africa Hereditary Angioedema Treatment Market Facts & Figures by Application
11 Company Profiles
- 11.1 CSL
- 11.1.1 CSL Corporation Information
- 11.1.2 CSL Description, Business Overview and Total Revenue
- 11.1.3 CSL Sales, Revenue and Gross Margin (2015-2020)
- 11.1.4 CSL Hereditary Angioedema Treatment Products Offered
- 11.1.5 CSL Recent Development
- 11.2 Pharming Group
- 11.2.1 Pharming Group Corporation Information
- 11.2.2 Pharming Group Description, Business Overview and Total Revenue
- 11.2.3 Pharming Group Sales, Revenue and Gross Margin (2015-2020)
- 11.2.4 Pharming Group Hereditary Angioedema Treatment Products Offered
- 11.2.5 Pharming Group Recent Development
- 11.3 Shire plc (Takeda Pharmaceutical Company Limited)
- 11.3.1 Shire plc (Takeda Pharmaceutical Company Limited) Corporation Information
- 11.3.2 Shire plc (Takeda Pharmaceutical Company Limited) Description, Business Overview and Total Revenue
- 11.3.3 Shire plc (Takeda Pharmaceutical Company Limited) Sales, Revenue and Gross Margin (2015-2020)
- 11.3.4 Shire plc (Takeda Pharmaceutical Company Limited) Hereditary Angioedema Treatment Products Offered
- 11.3.5 Shire plc (Takeda Pharmaceutical Company Limited) Recent Development
- 11.4 Ionis Pharmaceuticals
- 11.4.1 Ionis Pharmaceuticals Corporation Information
- 11.4.2 Ionis Pharmaceuticals Description, Business Overview and Total Revenue
- 11.4.3 Ionis Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
- 11.4.4 Ionis Pharmaceuticals Hereditary Angioedema Treatment Products Offered
- 11.4.5 Ionis Pharmaceuticals Recent Development
- 11.5 Attune Pharmaceuticals
- 11.5.1 Attune Pharmaceuticals Corporation Information
- 11.5.2 Attune Pharmaceuticals Description, Business Overview and Total Revenue
- 11.5.3 Attune Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
- 11.5.4 Attune Pharmaceuticals Hereditary Angioedema Treatment Products Offered
- 11.5.5 Attune Pharmaceuticals Recent Development
- 11.6 BioCryst Pharmaceuticals
- 11.6.1 BioCryst Pharmaceuticals Corporation Information
- 11.6.2 BioCryst Pharmaceuticals Description, Business Overview and Total Revenue
- 11.6.3 BioCryst Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
- 11.6.4 BioCryst Pharmaceuticals Hereditary Angioedema Treatment Products Offered
- 11.6.5 BioCryst Pharmaceuticals Recent Development
- 11.7 KalVista Pharmaceuticals
- 11.7.1 KalVista Pharmaceuticals Corporation Information
- 11.7.2 KalVista Pharmaceuticals Description, Business Overview and Total Revenue
- 11.7.3 KalVista Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
- 11.7.4 KalVista Pharmaceuticals Hereditary Angioedema Treatment Products Offered
- 11.7.5 KalVista Pharmaceuticals Recent Development
- 11.1 CSL
- 11.1.1 CSL Corporation Information
- 11.1.2 CSL Description, Business Overview and Total Revenue
- 11.1.3 CSL Sales, Revenue and Gross Margin (2015-2020)
- 11.1.4 CSL Hereditary Angioedema Treatment Products Offered
- 11.1.5 CSL Recent Development
12 Future Forecast by Regions (Countries) (2021-2026)
- 12.1 Hereditary Angioedema Treatment Market Estimates and Projections by Region
- 12.1.1 Global Hereditary Angioedema Treatment Sales Forecast by Regions 2021-2026
- 12.1.2 Global Hereditary Angioedema Treatment Revenue Forecast by Regions 2021-2026
- 12.2 North America Hereditary Angioedema Treatment Market Size Forecast (2021-2026)
- 12.2.1 North America: Hereditary Angioedema Treatment Sales Forecast (2021-2026)
- 12.2.2 North America: Hereditary Angioedema Treatment Revenue Forecast (2021-2026)
- 12.2.3 North America: Hereditary Angioedema Treatment Market Size Forecast by Country (2021-2026)
- 12.3 Europe Hereditary Angioedema Treatment Market Size Forecast (2021-2026)
- 12.3.1 Europe: Hereditary Angioedema Treatment Sales Forecast (2021-2026)
- 12.3.2 Europe: Hereditary Angioedema Treatment Revenue Forecast (2021-2026)
- 12.3.3 Europe: Hereditary Angioedema Treatment Market Size Forecast by Country (2021-2026)
- 12.4 Asia Pacific Hereditary Angioedema Treatment Market Size Forecast (2021-2026)
- 12.4.1 Asia Pacific: Hereditary Angioedema Treatment Sales Forecast (2021-2026)
- 12.4.2 Asia Pacific: Hereditary Angioedema Treatment Revenue Forecast (2021-2026)
- 12.4.3 Asia Pacific: Hereditary Angioedema Treatment Market Size Forecast by Region (2021-2026)
- 12.5 Latin America Hereditary Angioedema Treatment Market Size Forecast (2021-2026)
- 12.5.1 Latin America: Hereditary Angioedema Treatment Sales Forecast (2021-2026)
- 12.5.2 Latin America: Hereditary Angioedema Treatment Revenue Forecast (2021-2026)
- 12.5.3 Latin America: Hereditary Angioedema Treatment Market Size Forecast by Country (2021-2026)
- 12.6 Middle East and Africa Hereditary Angioedema Treatment Market Size Forecast (2021-2026)
- 12.6.1 Middle East and Africa: Hereditary Angioedema Treatment Sales Forecast (2021-2026)
- 12.6.2 Middle East and Africa: Hereditary Angioedema Treatment Revenue Forecast (2021-2026)
- 12.6.3 Middle East and Africa: Hereditary Angioedema Treatment Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Porter’s Five Forces Analysis
- 13.5 Primary Interviews with Key Hereditary Angioedema Treatment Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Hereditary Angioedema Treatment Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
Summary:
Get latest Market Research Reports on COVID-19 Impact on Global Hereditary Angioedema Treatment. Industry analysis & Market Report on COVID-19 Impact on Global Hereditary Angioedema Treatment is a syndicated market report, published as COVID-19 Impact on Global Hereditary Angioedema Treatment Market Insights, Forecast to 2026. It is complete Research Study and Industry Analysis of COVID-19 Impact on Global Hereditary Angioedema Treatment market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
